Aerie Pharmaceuticals Announces Appointment of Judith J. Robertson as Chief Commercial Officer
Aerie Pharmaceuticals, Inc | December 19, 2016
Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of glaucoma and other diseases of the eye, today announced the appointment of Judith J. Robertson as Chief Commercial Officer, reporting to Thomas Mitro, Aerie President and Chief Operating Officer…